⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTGN News
Vistagen Therapeutics, Inc. Common Stock
Vistagen Selects GATC Health to Apply Predictive AI Across Lead Clinical-Stage Drug Development Programs
globenewswire.com
VTGN
Form 8-K
sec.gov
VTGN
Form 8-K
sec.gov
VTGN
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
globenewswire.com
ONCO
SRXH
VTGN
GRML
Form 8-K
sec.gov
VTGN
Vistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder
globenewswire.com
VTGN
Form 8-K
sec.gov
VTGN
Vistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
globenewswire.com
VTGN
Half-year Financial Report
businesswire.com
BOOM
VTGN
Form 8-K
sec.gov
VTGN